NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Abalone Bio

Abalone Bio

Private
Emeryville, CaliforniaHealthcare & Life Scienceshttps://www.abalonebio.com/

Last Round

Grant

Apr 1, 2024

Total Funding Raised

$11.07M

Company Overview

Abalone Bio is a biotechnology company that develops activating antibody-based therapeutics for challenging diseases, including cancer, pain, inflammatory conditions, and metabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

antibody discoverydrug discoveryfunctional antibody selectionFAST platformGPCRG-protein coupled receptorsantibody agonistsAI drug discoveryprotein LLMmembrane proteingenerative biologyin silico drug designion channelstherapeutic antibodiesbiotech R&Dpreclinical development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abalone Bio Comparables

Compare Abalone Bio with similar companies based on industry and business-model similarity.

Abalone Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InterAx Biotech
79%
Octant
79%
Antiverse
78%

Abalone Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2024
GrantSep 12, 2022
GrantAug 1, 2022
GrantAug 19, 2021
GrantMay 1, 2021
Grant
Feb 1, 2021

Key People

Founding team and executive leadership

Richard Yu

Co-founder And CEO

Founding Team

Abalone Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 11, 2025

    Partnering with the University of Pennsylvania to develop obesity drugs.

  • Apr 1, 2024

    $399K grant received from National Institute on Drug Abuse.

Abalone Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Abalone Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abalone Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersEmeryville, California
Employee Range25
Year Founded2017
Last FundingApr 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.